RxDoctor Payments Data

Ira Webb, PA

Physician Assistant · Bluefield, VANPI 1720021447

Payments from drug & device makers

$880in general payments, 2019–2025

Across 48 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$283
  • Teva Pharmaceuticals USA, Inc.$199
  • Takeda Pharmaceuticals U.S.A., Inc.$104
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
  • Vanda Pharmaceuticals Inc.$63
  • E.r. Squibb & Sons, L.L.C.$60
  • plus $89 from 3 others

What the payments were for

  • Food & beverage$76187%
  • Education$11813%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$880 in reported general payments places this provider in the 70th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$14,235
Medicare patients
52
Services billed
187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide12$5,783
ViibrydVilazodone Hcl11$3,924
Gabapentin275$3,410
Risperidone350$2,731
Oxcarbazepine92$2,534
Clonazepam276$2,261
Alprazolam527$2,191
Mirtazapine156$2,015
Duloxetine Hcl113$1,617
Paliperidone ErPaliperidone16$1,548
Lorazepam290$1,443
Lamotrigine121$1,354
Bupropion Hcl SrBupropion Hcl107$1,353
Zolpidem Tartrate237$1,267
Citalopram HbrCitalopram Hydrobromide465$1,260

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$104$5,78312 claims
AbbVieViibryd$283$3,92411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Bluefield

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →